October 2, 2018 Tags: neuromodulator, botulinum toxin, Botox Nashville, Botox, Wrinkle Treatment, Dr. J.J. Wendel Plastic Surgery, Plastic Surgery News, Allergan
Allergan, the global pharmaceutical company behind Botox Cosmetic, Juvederm fillers and Kybella, announced that it is acquiring Bonti Inc. Bonti Inc has been developing a new neuromodulator called EB-001 to be used for both cosmetic and therapeutic use. Current neuromodulators on the market are Botox, Dysport, and Xeomin. These products take about a week for patients to see results while EB-001 is expected to take effect within 24 hours.
Learn more with this article: http://www.plasticsurgerypractice.com/2018/09/botox-maker-allergan-just-acquired-revolutionary-new-neuromodulator/?ref=fr-title
